Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
2026-02-19QTTBSCHEDULE 13GSchedule 13G Filing by Point72 Asset Management, L.P. for Q32 Bio Inc.HIGH
Point72 Asset Management, L.P., along with Point72 Capital Advisors, Inc. and Steven A. Cohen, have jointly filed a Schedule 13G, reporting beneficial ownership of 9.9% of Q32 Bio Inc.'s common stock. This ownership, amounting to 2,057,308 shares, is held through Point72 Associates, an investment fund managed by Point7...
Micro CapBiotechnologyownership +9.90%
2026-02-19FORRSCHEDULE 13GPortolan Capital Management, LLC Increases Stake in Forrester Research, Inc.MEDIUM
Portolan Capital Management, LLC, an investment manager, and its manager George McCabe have reported acquiring a 6.12% stake in Forrester Research, Inc. (FORR). The filing indicates that Portolan Capital Management, LLC beneficially owns 1,163,008 shares of Common Stock, par value $0.01, representing 6.12% of the class...
Micro CapConsulting Servicesownership +6.12%
2026-02-19PWSCHEDULE 13GBradley & Daytona Railway and Land Co. LLC Acquires 5.00% Stake in Power REITMEDIUM
Bradley & Daytona Railway and Land Co. LLC has acquired a 5.00% ownership stake in Power REIT, as reported in a SCHEDULE 13G filing. The filing indicates that Bradley & Daytona Railway and Land Co. LLC beneficially owns 16,860.00 shares of Power REIT's Series A Cumulative Redeemable Perpetual Preferred Stock. The compa...
Nano CapREIT - Specialtyownership +5.00%
2026-02-19PCAPSCHEDULE 13GNotice of Shareholder MeetingMEDIUM
RP Investment Advisors LP, along with affiliated funds RP Select Opportunities Master Fund Ltd., RP Debt Opportunities Fund Ltd., RP Alternative Global Bond Fund, and RP Alternative Credit Opportunities Fund, has jointly filed a Schedule 13G with the SEC. This filing indicates their beneficial ownership of ProCap Acqui...
Small Capownership +5.60%
2026-02-19Point72 Asset Management, L.P.SCHEDULE 13GSchedule 13G Filing by Point72 Asset Management, L.P. for Q32 Bio Inc.DuplicateHIGH
Point72 Asset Management, L.P., along with Point72 Capital Advisors, Inc. and Steven A. Cohen, have jointly filed a Schedule 13G, reporting beneficial ownership of 9.9% of Q32 Bio Inc.'s common stock. This ownership, amounting to 2,057,308 shares, is held through Point72 Associates, an investment fund managed by Point7...
Micro CapBiotechnologyownership +9.90%
2026-02-19ProCap Acquisition CorpSCHEDULE 13GNotice of Shareholder MeetingDuplicateMEDIUM
RP Investment Advisors LP, along with affiliated funds RP Select Opportunities Master Fund Ltd., RP Debt Opportunities Fund Ltd., RP Alternative Global Bond Fund, and RP Alternative Credit Opportunities Fund, has jointly filed a Schedule 13G with the SEC. This filing indicates their beneficial ownership of ProCap Acqui...
Small Capownership +5.60%
2026-02-19SLRCSCHEDULE 13GTHORNBURG INVESTMENT MANAGEMENT INC. Acquires 8.01% Stake in SLR Investment CorpHIGH
THORNBURG INVESTMENT MANAGEMENT INC. has reported a beneficial ownership of 8.01% in SLR Investment Corp as of December 31, 2025. The investment firm now holds 4,372,550 shares, with sole voting and dispositive power over all of them. This filing, designated under Rule 13d-1(b), indicates that the securities were acqui...
Small CapAsset Managementownership +8.01%
Sponsored
2026-02-19LRHCSCHEDULE 13GSchedule 13G Filing by SZOP Opportunities Management LLC and SZOP Opportunities I LLCMEDIUM
This filing reports that SZOP Opportunities I LLC, managed by SZOP Opportunities Management LLC, may acquire up to 9.9% of La Rosa Holdings Corp. common stock through an Equity Purchase Facility Agreement. As of February 19, 2026, they hold 59,378 shares, representing 9.9% ownership, subject to an ownership limitation....
Nano CapReal Estate Servicesownership +9.90%
2026-02-19SOCSCHEDULE 13GFourWorld Capital Management LLC Acquires 5.8% Stake in Sable Offshore Corp.MEDIUM
FourWorld Capital Management LLC, through John Addis, has reported acquiring beneficial ownership of 8,412,108 shares of Sable Offshore Corp. common stock, representing 5.8% of the class. This acquisition occurred as of December 31, 2025, and was filed on a Schedule 13G on February 19, 2026. The filing indicates that t...
Small CapOil & Gas Drillingownership +5.80%
2026-02-19IMUXSCHEDULE 13GSchedule 13G Filing by Soleus Capital Master Fund, L.P.MEDIUM
Soleus Capital Master Fund, L.P. and its related entities, including Soleus Capital, LLC, Soleus Capital Group, LLC, Soleus Capital Management, L.P., Soleus GP, LLC, and Guy Levy, have jointly filed a Schedule 13G, reporting beneficial ownership of IMMUNIC, INC. common stock. As of February 19, 2026, Soleus Capital Mas...
Micro CapBiotechnologyownership +5.50%
2026-02-19SLR Investment Corp.SCHEDULE 13GTHORNBURG INVESTMENT MANAGEMENT INC. Acquires 8.01% Stake in SLR Investment CorpDuplicateHIGH
THORNBURG INVESTMENT MANAGEMENT INC. has reported a beneficial ownership of 8.01% in SLR Investment Corp as of December 31, 2025. The investment firm now holds 4,372,550 shares, with sole voting and dispositive power over all of them. This filing, designated under Rule 13d-1(b), indicates that the securities were acqui...
Small CapAsset Managementownership +8.01%
2026-02-19CIMSCHEDULE 13GTHORNBURG INVESTMENT MANAGEMENT INC. Increases Stake in Chimera Investment CorpMEDIUM
Thornburg Investment Management Inc. has increased its beneficial ownership in Chimera Investment Corp. The filing indicates that as of December 31, 2025, Thornburg Investment Management Inc. beneficially owns 5,269,354 shares of Chimera Investment Corp common stock, representing 6.34% of the class. This represents an ...
Small CapREIT - Mortgageownership +6.34%
2026-02-19VTYXSCHEDULE 13GInitial Filing of Beneficial Ownership for Ventyx Biosciences, Inc. by Glazer Capital, LLCHIGH
Glazer Capital, LLC, along with Paul J. Glazer, has filed a Schedule 13G indicating their beneficial ownership of 4,446,004 shares of Ventyx Biosciences, Inc. common stock, representing 6.23% of the outstanding shares. This ownership is held through various Glazer Funds managed by Glazer Capital, with Paul J. Glazer, a...
Small CapBiotechnologyownership +6.23%
2026-02-19PBMSCHEDULE 13GForm 13G Filing by Weiner Jeffrey David for Psyence Biomedical Ltd.
Weiner Jeffrey David, a United States citizen, has filed a Schedule 13G, reporting beneficial ownership of 51,850 shares of Psyence Biomedical Ltd. common stock, representing 5.07% of the class. This filing indicates that the securities were not acquired and are not held for the purpose of or with the effect of changin...
Nano CapBiotechnologyownership +5.07%
Sponsored
2026-02-19XFLHSCHEDULE 13GFeis Equities LLC Beneficial Ownership Filing for XFLH Capital Corp
Feis Equities LLC, through Lawrence M. Feis, has reported beneficial ownership of 585,475 Ordinary Shares of XFLH Capital Corp, representing 5.85% of the class. This filing, dated February 18, 2026, confirms that the shares were not acquired or held for the purpose of changing or influencing the control of the issuer. ...
ownership +5.85%